Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Drug Discovery

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1643511

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1643511

Artificial Intelligence in Predictive Toxicology

PUBLISHED:
PAGES: 206 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Artificial Intelligence in Predictive Toxicology Market to Reach US$2.2 Billion by 2030

The global market for Artificial Intelligence in Predictive Toxicology estimated at US$508.8 Million in the year 2024, is expected to reach US$2.2 Billion by 2030, growing at a CAGR of 27.5% over the analysis period 2024-2030. AI in Predictive Toxicology Solutions, one of the segments analyzed in the report, is expected to record a 24.8% CAGR and reach US$1.4 Billion by the end of the analysis period. Growth in the AI in Predictive Toxicology Services segment is estimated at 33.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$133.7 Million While China is Forecast to Grow at 26.2% CAGR

The Artificial Intelligence in Predictive Toxicology market in the U.S. is estimated at US$133.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$333.3 Million by the year 2030 trailing a CAGR of 26.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 24.7% and 24.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 19.3% CAGR.

Global Artificial Intelligence in Predictive Toxicology Market - Key Trends & Drivers Summarized

How Is AI Revolutionizing Toxicology Testing?

Artificial Intelligence (AI) is transforming toxicology by enabling faster, more accurate, and cost-effective methods for predicting the toxicity of chemicals and substances. Traditional toxicological assessments, which often rely on animal testing and lengthy experimental procedures, are being replaced by AI-powered predictive models that simulate human responses based on large datasets. AI leverages machine learning (ML), deep learning (DL), and data analytics to analyze molecular structures and predict potential toxic effects with high precision.

One of the key applications of AI in predictive toxicology is its ability to identify toxic substances at an early stage of drug development or chemical manufacturing. By analyzing vast datasets from chemical properties, biological interactions, and experimental results, AI systems can quickly identify compounds that are likely to be harmful. This accelerates the development process and significantly reduces the time and cost associated with safety testing. AI’s ability to predict toxicity in various biological systems also reduces the reliance on animal testing, aligning with ethical and regulatory standards.

AI models also enhance the ability to predict the long-term effects of exposure to chemicals, such as carcinogenicity, reproductive toxicity, and neurotoxicity. These capabilities are crucial for industries such as pharmaceuticals, chemicals, and environmental safety, where early identification of harmful substances can save lives and prevent regulatory violations.

What Drives the Adoption of AI in Predictive Toxicology?

The growing emphasis on safety and regulatory compliance is a significant driver of AI adoption in predictive toxicology. With increasing global concerns about environmental pollution, chemical exposure, and the ethical implications of animal testing, AI offers a promising alternative to traditional toxicology practices. AI systems provide regulatory bodies and industries with more reliable, scalable, and accurate methods for assessing chemical safety.

Additionally, the rise of precision medicine and personalized health care is accelerating the need for advanced predictive tools in toxicology. As more individualized drugs are developed, understanding how specific compounds affect different genetic profiles becomes increasingly important. AI’s ability to analyze complex biological data and predict toxicological effects based on an individual’s genetic makeup enhances drug safety and efficacy, ensuring that treatments are tailored to specific patient groups.

The shift toward more efficient and sustainable research practices is also driving the adoption of AI in predictive toxicology. Traditional toxicological studies can be time-consuming and expensive, while AI systems enable high-throughput screening and rapid toxicity predictions. This reduces the overall cost of product development, particularly in the pharmaceutical, chemical, and consumer goods industries, where safety testing is critical to market entry.

Can AI Improve the Accuracy and Efficiency of Toxicity Prediction?

AI is significantly improving the accuracy and efficiency of toxicity prediction, addressing the limitations of conventional methods. Traditional toxicology testing often involves extensive in vivo studies, which can be costly and time-consuming. AI algorithms, by analyzing large datasets of chemical properties and biological outcomes, can predict toxicity with a level of accuracy and speed that is far superior to manual methods. These AI-driven models can rapidly analyze millions of compounds, prioritizing those that need further investigation.

Furthermore, AI systems improve prediction accuracy by accounting for complex variables that influence toxicity, such as metabolic processes and genetic variations. By integrating data from genomics, proteomics, and other disciplines, AI enhances the predictive capabilities of toxicology models, making them more robust and reliable. This enables early-stage detection of potential safety concerns, leading to safer chemicals and drugs entering the market.

Another major advantage of AI in predictive toxicology is its ability to continuously learn from new data. As more toxicological data becomes available, machine learning algorithms refine their predictions, improving over time. This iterative learning process ensures that AI systems remain at the forefront of accuracy, enabling better risk assessments and improving safety profiles for chemicals and pharmaceuticals.

What’s Driving the Growth of the AI in Predictive Toxicology Market?

The growth in the Artificial Intelligence in Predictive Toxicology market is driven by several key factors, reflecting the increasing demand for safer and more efficient testing methods. The rising global demand for pharmaceutical and chemical products, coupled with stringent safety regulations, is fueling the need for advanced predictive toxicology tools. AI offers an efficient, scalable solution to meet these demands, significantly reducing the cost and time required for toxicity testing.

The growing shift toward sustainable and ethical testing methods is also propelling AI adoption. As public and regulatory pressure to reduce animal testing increases, AI-powered models offer a viable alternative for assessing chemical safety without the ethical concerns associated with animal studies.

Technological advancements in AI, such as deep learning, big data analytics, and high-performance computing, are enhancing the predictive capabilities of toxicology models. These innovations are enabling AI systems to process vast amounts of data from various sources, improving the accuracy of toxicity predictions.

Finally, the integration of AI in environmental safety and the growing importance of regulatory compliance are supporting the adoption of AI-driven predictive toxicology tools across multiple industries. These factors, combined with increasing investments in AI research, are fueling the rapid growth of the market and establishing AI as a key player in the future of toxicology testing.

SCOPE OF STUDY:

The report analyzes the Artificial Intelligence in Predictive Toxicology market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Solutions Component, Services Component); Technology (Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology, Other Technologies); Toxicity Endpoint (Genotoxicity Endpoint, Hepatotoxicity Endpoint, Neurotoxicity Endpoint, Cardiotoxicity Endpoint, Other Toxicity Endpoints); End-Use (Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 36 Featured) -

  • AbbVie, Inc.
  • BenevolentAI
  • Biovista Inc.
  • ChemAxon
  • Exscientia Plc
  • Insilico Medicine
  • Instem Plc
  • Lhasa Limited
  • Recursion Pharmaceuticals
Show more
Product Code: MCP29264

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Economic Frontiers: Trends, Trials & Transformations
    • Artificial Intelligence in Predictive Toxicology - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Preclinical Drug Testing Needs Drive Growth of AI-Driven Toxicity Prediction Models
    • Demand for AI in Reducing Animal Testing Strengthens Case for Ethical Toxicology Solutions
    • AI-Enhanced Toxicology Workflows Drive Market Demand in Drug Safety Assessment
    • Emerging AI Tools for Environmental Toxicology Highlight Market Potential
    • AI Models for Carcinogenicity Prediction Spur Growth in Chemical Risk Assessment
    • Advancements in AI for Neurotoxicity Screening Propel Innovation in CNS Drug Development
    • AI Solutions for Predictive Risk Assessment Sustain Growth in Consumer Product Testing
    • AI in Food Toxicology Highlights Opportunities for Safer Food Additives
    • AI-Driven Endocrine Disruptor Screening Strengthens Case for Safer Product Formulation
    • Integration of AI in Nanotoxicology Sets the Stage for Innovations in Material Safety
    • AI Tools for Dermal Toxicity Testing Propel Growth in Cosmetic Safety Markets
    • Growing Focus on AI in Reproductive Toxicity Studies Bodes Well for Regulatory Adherence
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Artificial Intelligence in Predictive Toxicology Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Solutions Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Solutions Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Services Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Services Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Cardiotoxicity Endpoint by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Cardiotoxicity Endpoint by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other Toxicity Endpoints by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Other Toxicity Endpoints by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Genotoxicity Endpoint by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Genotoxicity Endpoint by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hepatotoxicity Endpoint by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Hepatotoxicity Endpoint by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Neurotoxicity Endpoint by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Neurotoxicity Endpoint by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Pharma & Biotech Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Chemical & Cosmetics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Chemical & Cosmetics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Contract Research Organizations End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Contract Research Organizations End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Machine Learning Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Machine Learning Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Natural Language Processing Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 29: World 6-Year Perspective for Natural Language Processing Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 30: World Recent Past, Current & Future Analysis for Computer Vision Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 31: World 6-Year Perspective for Computer Vision Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World 6-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Artificial Intelligence in Predictive Toxicology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 34: USA Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: USA 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 36: USA Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: USA 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Percentage Breakdown of Value Sales for Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint for the Years 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by End-Use - Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 40: USA Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Technology - Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: USA 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Technology - Percentage Breakdown of Value Sales for Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies for the Years 2025 & 2030
  • CANADA
    • TABLE 42: Canada Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Canada 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Percentage Breakdown of Value Sales for Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint for the Years 2025 & 2030
    • TABLE 46: Canada Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by End-Use - Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Canada 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 48: Canada Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Technology - Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Canada 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Technology - Percentage Breakdown of Value Sales for Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies for the Years 2025 & 2030
  • JAPAN
    • Artificial Intelligence in Predictive Toxicology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 52: Japan Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Japan 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Percentage Breakdown of Value Sales for Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint for the Years 2025 & 2030
    • TABLE 54: Japan Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by End-Use - Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Japan 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Technology - Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Technology - Percentage Breakdown of Value Sales for Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies for the Years 2025 & 2030
  • CHINA
    • Artificial Intelligence in Predictive Toxicology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 58: China Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: China 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 60: China Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: China 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Percentage Breakdown of Value Sales for Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint for the Years 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by End-Use - Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 64: China Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Technology - Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: China 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Technology - Percentage Breakdown of Value Sales for Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies for the Years 2025 & 2030
  • EUROPE
    • Artificial Intelligence in Predictive Toxicology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 66: Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 67: Europe 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 70: Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Europe 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Percentage Breakdown of Value Sales for Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint for the Years 2025 & 2030
    • TABLE 72: Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by End-Use - Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Europe 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Technology - Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Technology - Percentage Breakdown of Value Sales for Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies for the Years 2025 & 2030
  • FRANCE
    • Artificial Intelligence in Predictive Toxicology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 76: France Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: France 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 78: France Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: France 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Percentage Breakdown of Value Sales for Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint for the Years 2025 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by End-Use - Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 82: France Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Technology - Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: France 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Technology - Percentage Breakdown of Value Sales for Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies for the Years 2025 & 2030
  • GERMANY
    • Artificial Intelligence in Predictive Toxicology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 84: Germany Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Germany 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Percentage Breakdown of Value Sales for Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint for the Years 2025 & 2030
    • TABLE 88: Germany Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by End-Use - Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Germany 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 90: Germany Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Technology - Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Germany 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Technology - Percentage Breakdown of Value Sales for Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies for the Years 2025 & 2030
  • ITALY
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Italy 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 94: Italy Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Italy 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Percentage Breakdown of Value Sales for Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint for the Years 2025 & 2030
    • TABLE 96: Italy Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by End-Use - Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Italy 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Technology - Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Technology - Percentage Breakdown of Value Sales for Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies for the Years 2025 & 2030
  • UNITED KINGDOM
    • Artificial Intelligence in Predictive Toxicology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 100: UK Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 101: UK 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 102: UK Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 103: UK 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Percentage Breakdown of Value Sales for Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint for the Years 2025 & 2030
    • TABLE 104: UK Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by End-Use - Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 106: UK Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Technology - Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 107: UK 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Technology - Percentage Breakdown of Value Sales for Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 108: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 109: Rest of Europe 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Rest of Europe 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Percentage Breakdown of Value Sales for Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint for the Years 2025 & 2030
    • TABLE 112: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by End-Use - Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 113: Rest of Europe 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 114: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Technology - Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 115: Rest of Europe 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Technology - Percentage Breakdown of Value Sales for Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Artificial Intelligence in Predictive Toxicology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 118: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 119: Asia-Pacific 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Percentage Breakdown of Value Sales for Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint for the Years 2025 & 2030
    • TABLE 120: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by End-Use - Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 121: Asia-Pacific 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Technology - Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Technology - Percentage Breakdown of Value Sales for Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 124: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Component - Solutions Component and Services Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 125: Rest of World 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Component - Percentage Breakdown of Value Sales for Solutions Component and Services Component for the Years 2025 & 2030
    • TABLE 126: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 127: Rest of World 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Toxicity Endpoint - Percentage Breakdown of Value Sales for Cardiotoxicity Endpoint, Other Toxicity Endpoints, Genotoxicity Endpoint, Hepatotoxicity Endpoint and Neurotoxicity Endpoint for the Years 2025 & 2030
    • TABLE 128: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by End-Use - Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of World 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Chemical & Cosmetics End-Use, Contract Research Organizations End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 130: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence in Predictive Toxicology by Technology - Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 131: Rest of World 6-Year Perspective for Artificial Intelligence in Predictive Toxicology by Technology - Percentage Breakdown of Value Sales for Machine Learning Technology, Natural Language Processing Technology, Computer Vision Technology and Other Technologies for the Years 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!